ID LP-1 AC CVCL_0012 SY LP1 DR BTO; BTO_0005912 DR CLO; CLO_0007379 DR EFO; EFO_0003055 DR CLDB; cl3252 DR AddexBio; C0003006/55 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-2706 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR ArrayExpress; E-MTAB-7721 DR ArrayExpress; E-MTAB-7722 DR ArrayExpress; E-TABM-937 DR BioGRID_ORCS_Cell_line; 933 DR BioSample; SAMN03472929 DR BioSample; SAMN10988493 DR cancercelllines; CVCL_0012 DR Cell_Model_Passport; SIDM00340 DR ChEMBL-Cells; CHEMBL3308171 DR ChEMBL-Targets; CHEMBL2366066 DR CLS; 300321 DR Cosmic; 720763 DR Cosmic; 759910 DR Cosmic; 907791 DR Cosmic; 2081397 DR Cosmic; 2367290 DR Cosmic; 2391810 DR Cosmic; 2809761 DR Cosmic-CLP; 907791 DR DepMap; ACH-000204 DR DSMZ; ACC-41 DR DSMZCellDive; ACC-41 DR EGA; EGAS00001000610 DR EGA; EGAS00001000978 DR EGA; EGAS00001002554 DR GDSC; 907791 DR GEO; GSM143335 DR GEO; GSM290302 DR GEO; GSM562813 DR GEO; GSM887276 DR GEO; GSM888351 DR GEO; GSM1374631 DR GEO; GSM1670057 DR IARC_TP53; 21475 DR LiGeA; CCLE_549 DR LINCS_LDP; LCL-2046 DR Lonza; 129 DR PharmacoDB; LP1_858_2019 DR PRIDE; PXD030239 DR PRIDE; PXD030304 DR Progenetix; CVCL_0012 DR PubChem_Cell_line; CVCL_0012 DR Wikidata; Q54902910 RX CelloPub=CLPUB00604; RX DOI=10.1007/0-306-46877-8_4; RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=2784066; RX PubMed=10583232; RX PubMed=10936422; RX PubMed=11157491; RX PubMed=16956823; RX PubMed=16957166; RX PubMed=17171682; RX PubMed=17692805; RX PubMed=18647998; RX PubMed=18700954; RX PubMed=20164919; RX PubMed=21173094; RX PubMed=22460905; RX PubMed=25485619; RX PubMed=25688540; RX PubMed=25877200; RX PubMed=25984343; RX PubMed=26589293; RX PubMed=27397505; RX PubMed=28196595; RX PubMed=30285677; RX PubMed=30545397; RX PubMed=30894373; RX PubMed=30971826; RX PubMed=31068700; RX PubMed=31160637; RX PubMed=32123307; RX PubMed=35839778; WW Info; HPA; -; https://www.proteinatlas.org/learn/cellines WW Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: LL-100 blood cancer cell line panel. CC Part of: MD Anderson Cell Lines Project. CC Population: Caucasian. CC Characteristics: Produces IgG lambda. CC Doubling time: 50 hours (PubMed=2784066); 48 hours (PubMed=25984343); 35-80 hours (Note=Depending on cell density) (DSMZ=ACC-41). CC HLA typing: A*03,24; B*07,18; C*07 (PubMed=25688540). CC HLA typing: A*26:01,30:01; B*18:01,35:03; C*04:01,07:01; DQA1*03:02,05:01; DQB1*03:02,03:02; DRB1*04:03,11:04 (PubMed=26589293). CC HLA typing: A*26:01:01,30:01:01; B*18:01:01,35:03:01; C*04:01:01;07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:01:01; DQA1*03:01:01,05:05:01; DQB1*03:01:01,03:02:01; DRA*01:01:01,01:01:01; DRB1*04:03:01,11:04:01 (DSMZCellDive=ACC-41). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:12766; NSD2; Name(s)=IGH-NSD2, IGH-WHSC1 (PubMed=31160637). CC Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe384Leu (c.1150T>C) (F386L); ClinVar=VCV000134404; Zygosity=Unspecified (PubMed=11157491). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=907791). CC Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys286Ilefs*7 (c.857_870delAGAGCATACAAAGT); Zygosity=Homozygous (PubMed=17692805). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Expression; Large antibody panel staining analysis. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; Array-based CGH. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.21%; Native American=0%; East Asian, North=3.2%; East Asian, South=0%; South Asian=2.32%; European, North=42.82%; European, South=51.44% (PubMed=30894373). CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: Plasma cell; CL=CL_0000786. ST Source(s): Cosmic-CLP=907791; DSMZ=ACC-41; PubMed=25877200 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 12 ST D16S539: 11,12 ST D18S51: 18 ST D19S433: 14 ST D21S11: 30,31 ST D2S1338: 18,26 ST D3S1358: 16,18 ST D5S818: 11 ST D7S820: 11,12 ST D8S1179: 13 (DSMZ=ACC-41) ST D8S1179: 13,15 (PubMed=25877200) ST FGA: 20,21 ST Penta D: 12 ST Penta E: 10,11 ST TH01: 7,8 ST TPOX: 11 ST vWA: 17 DI NCIt; C3242; Plasma cell myeloma DI ORDO; Orphanet_29073; Multiple myeloma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 56Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 47 // RX PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2; RA Drexler, Hans Gunther RA Matsuo, Yoshinobu RT "Malignant hematopoietic cell lines: in vitro models for the study of RT multiple myeloma and plasma cell leukemia."; RL Leuk. Res. 24:681-703(2000). // RX PubMed=16956823; RA Bataille, Francois-Regis RA Jego, Gaatan RA Robillard, Nelly RA Barille-Nion, Sophie RA Harousseau, Jean-Luc RA Moreau, Philippe RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "The phenotype of normal, reactive and malignant plasma cells. RT Identification of 'many and multiple myelomas' and of new targets for RT myeloma therapy."; RL Haematologica 91:1234-1240(2006). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=21173094; DOI=10.3324/haematol.2010.033456; PMCID=PMC3069235; RA Moreaux, Jerome RA Klein, Bernard RA Bataille, Francois-Regis RA Descamps, Geraldine RA Maiga, Sophie RA Hose, Dirk RA Goldschmidt, Hartmut RA Jauch, Anna RA Reme, Thierry RA Jourdan, Michel RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "A high-risk signature for patients with multiple myeloma established RT from the molecular classification of human myeloma cell lines."; RL Haematologica 96:574-582(2011). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=11157491; DOI=10.1182/blood.V97.3.729; RA Chesi, Marta RA Brents, Leslie A. RA Ely, Sarah A. RA Bais, Carlos RA Robbiani, Davide F. RA Mesri, Enrique A. RA Kuehl, Walter Michael RA Bergsagel, Peter Leif RT "Activated fibroblast growth factor receptor 3 is an oncogene that RT contributes to tumor progression in multiple myeloma."; RL Blood 97:729-736(2001). // RX PubMed=25688540; DOI=10.1002/cyto.a.22643; RA Maiga, Sophie RA Brosseau, Carole RA Descamps, Geraldine RA Dousset, Christelle RA Gomez-Bougie, Patricia RA Chiron, David RA Menoret, Emmanuelle RA Kervoelen, Charlotte RA Vie, Henri RA Cesbron, Anne RA Moreau-Aubry, Agnes RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "A simple flow cytometry-based barcode for routine authentication of RT multiple myeloma and mantle cell lymphoma cell lines."; RL Cytometry A 87:285-288(2015). // RX PubMed=2784066; DOI=10.1182/blood.V73.4.1020.1020; RA Pegoraro, Luigi RA Malavasi, Fabio RA Bellone, Graziella RA Massaia, Massimo RA Boccadoro, Mario RA Saglio, Giuseppe RA Guerrasio, Angelo RA Benetton, Gabriella RA Lombardi, Luisa RA Coda, Renato RA Avanzi, Gian Carlo RT "The human myeloma cell line LP-1: a versatile model in which to study RT early plasma-cell differentiation and c-myc activation."; RL Blood 73:1020-1027(1989). // RX PubMed=18647998; DOI=10.1093/jncimonographs/lgn011; PMCID=PMC2737184; RA Dib, Amel RA Gabrea, Ana RA Glebov, Oleg K. RA Bergsagel, Peter Leif RA Kuehl, Walter Michael RT "Characterization of MYC translocations in multiple myeloma cell RT lines."; RL J. Natl. Cancer Inst. Monogr. 39:25-31(2008). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=30545397; DOI=10.1186/s13045-018-0679-0; PMCID=PMC6293660; RA Tessoulin, Benoit RA Moreau-Aubry, Agnes RA Descamps, Geraldine RA Gomez-Bougie, Patricia RA Maiga, Sophie RA Gaignard, Alban RA Chiron, David RA Menoret, Emmanuelle RA Le Gouill, Steven RA Moreau, Philippe RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "Whole-exon sequencing of human myeloma cell lines shows mutations RT related to myeloma patients at relapse with major hits in the DNA RT regulation and repair pathways."; RL J. Hematol. Oncol. 11:137.1-137.13(2018). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=32123307; DOI=10.1038/s41375-020-0785-1; PMCID=PMC7483300; RA Sarin, Vishesh RA Yu, Katharine RA Ferguson, Ian D. RA Gugliemini, Olivia RA Nix, Matthew A. RA Hann, Byron RA Sirota, Marina RA Wiita, Arun P. RT "Evaluating the efficacy of multiple myeloma cell lines as models for RT patient tumors via transcriptomic correlation analysis."; RL Leukemia 34:2754-2765(2020). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786; RA Tan, Kar-Tong RA Ding, Ling-Wen RA Sun, Qiao-Yang RA Lao, Zhen-Tang RA Chien, Wenwen RA Ren, Xi RA Xiao, Jin-Fen RA Loh, Xin-Yi RA Xu, Liang RA Lill, Michael RA Mayakonda, Anand RA Lin, De-Chen RA Yang, Henry He RA Koeffler, Harold Phillip RT "Profiling the B/T cell receptor repertoire of lymphocyte derived cell RT lines."; RL BMC Cancer 18:940.1-940.13(2018). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, Agda Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX DOI=10.1007/0-306-46877-8_4; RA Jernberg-Wiklund, Helena RA Nilsson, Kenneth RT "Multiple myeloma cell lines."; RL (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000). // RX PubMed=18700954; DOI=10.1186/1755-8794-1-37; PMCID=PMC2531129; RA Ronchetti, Domenica RA Lionetti, Marta RA Mosca, Laura RA Agnelli, Luca RA Andronache, Adrian RA Fabris, Sonia RA Lambertenghi-Deliliers, Giorgio RA Neri, Antonino RT "An integrative genomic approach reveals coordinated expression of RT intronic miR-335, miR-342, and miR-561 with deregulated host genes in RT multiple myeloma."; RL BMC Med. Genomics 1:37.1-37.9(2008). // RX PubMed=16957166; DOI=10.1369/jhc.6A7001.2006; PMCID=PMC3958123; RA Andersson, Ann-Catrin RA Stromberg, Sara RA Backvall, Helena RA Kampf, Caroline RA Uhlen, Mathias RA Wester, Kenneth RA Ponten, Fredrik RT "Analysis of protein expression in cell microarrays: a tool for RT antibody-based proteomics."; RL J. Histochem. Cytochem. 54:1413-1423(2006). // RX PubMed=10583232; DOI=10.1046/j.1365-2141.1999.01705.x; RA Puthier, Denis RA Derenne, Sophie RA Barille, Sophie RA Moreau, Philippe RA Harousseau, Jean-Luc RA Bataille, Francois-Regis RA Amiot, Martine RT "Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells."; RL Br. J. Haematol. 107:392-395(1999). // RX PubMed=17171682; DOI=10.1002/gcc.20404; RA Lombardi, Luigia RA Poretti, Giulia RA Mattioli, Michela RA Fabris, Sonia RA Agnelli, Luca RA Bicciato, Silvio RA Kwee, Ivo RA Rinaldi, Andrea RA Ronchetti, Domenica RA Verdelli, Donata RA Lambertenghi-Deliliers, Giorgio RA Bertoni, Francesco RA Neri, Antonino RT "Molecular characterization of human multiple myeloma cell lines by RT integrative genomics: insights into the biology of the disease."; RL Genes Chromosomes Cancer 46:226-238(2007). // RX PubMed=17692805; DOI=10.1016/j.ccr.2007.07.003; PMCID=PMC2083698; RA Keats, Jonathan J. RA Fonseca, Rafael RA Chesi, Marta RA Schop, Roelandt RA Baker, Angela RA Chng, Wee-Joo RA Van Wier, Scott RA Tiedemann, Rodger RA Shi, Chang-Xin RA Sebag, Michael RA Braggio, Esteban RA Henry, Travis RA Zhu, Yuan-Xiao RA Fogle, Homer RA Price-Troska, Tammy L. RA Ahmann, Gregory J. RA Mancini, Catherine RA Brents, Leslie A. RA Kumar, Shaji K. RA Greipp, Philip Robert RA Dispenzieri, Angela RA Bryant, Barb RA Mulligan, George RA Bruhn, Laurakay RA Barrett, Michael T. RA Valdez, Riccardo RA Trent, Jeffrey M. RA Stewart, A. Keith RA Carpten, John D. RA Bergsagel, Peter Leif RT "Promiscuous mutations activate the noncanonical NF-kappaB pathway in RT multiple myeloma."; RL Cancer Cell 12:131-144(2007). // RX PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646; RA Quentmeier, Hilmar RA Pommerenke, Claudia RA Dirks, Wilhelm Gerhard RA Eberth, Sonja RA Koeppel, Max RA MacLeod, Roderick A.F. RA Nagel, Stefan RA Steube, Klaus G. RA Uphoff, Cord C. RA Drexler, Hans Gunther RT "The LL-100 panel: 100 cell lines for blood cancer studies."; RL Sci. Rep. 9:8218.1-8218.14(2019). // RX PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652; RA Cowley, Glenn S. RA Weir, Barbara A. RA Vazquez, Francisca RA Tamayo, Pablo RA Scott, Justine A. RA Rusin, Scott RA East-Seletsky, Alexandra RA Ali, Levi D. RA Gerath, William F.J. RA Pantel, Sarah E. RA Lizotte, Patrick Hall RA Jiang, Guo-Zhi RA Hsiao, Jessica RA Tsherniak, Aviad RA Dwinell, Elizabeth RA Aoyama, Simon RA Okamoto, Michael RA Harrington, William RA Gelfand, Ellen T. RA Green, Thomas M. RA Tomko, Mark J. RA Gopal, Shuba RA Wong, Terence C. RA Li, Hu-Bo RA Howell, Sara RA Stransky, Nicolas RA Liefeld, Ted RA Jang, Dongkeun RA Bistline, Jonathan RA Meyers, Barbara Hill RA Armstrong, Scott Allen RA Anderson, Kenneth Carl RA Stegmaier, Kimberly RA Reich, Michael RA Pellman, David RA Boehm, Jesse S. RA Mesirov, Jill P. RA Golub, Todd Robert RA Root, David E. RA Hahn, William Chun RT "Parallel genome-scale loss of function screens in 216 cancer cell RT lines for the identification of context-specific genetic RT dependencies."; RL Sci. Data 1:140035.1-140035.12(2014). // RX CelloPub=CLPUB00604; RA Chow, Sharon RT "Targeted capture and sequencing of immunoglobulin rearrangements RT in multiple myeloma to enable detection of minimal residual disease."; RL Thesis MSc (2017); University of Toronto; Toronto; Canada. // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). //